Vertex Pharmaceuticals Incorporated Competitors
| Symbol | Share Price | Market Cap | P/E Ratio | Employee Count | Revenue |
|---|---|---|---|---|---|
ALNY
Alnylam Pharmaceuticals, Inc. |
$243.25 | $19.33 B | -57.65 | 2100 | $1.83 B |
BEAM
Beam Therapeutics Inc. |
$28.81 | $1.91 B | -14.51 | 472 | $377.71 M |
BMRN
BioMarin Pharmaceutical Inc. |
$66.63 | $15.32 B | 76.12 | 3401 | $2.42 B |
BNTX
BioNTech SE |
$114.13 | $23.85 B | 196.75 | 6133 | $3.82 B |
CRBU
Caribou Biosciences, Inc. |
$1.69 | $176.12 M | -1.41 | 158 | $34.48 M |
CRSP
CRISPR Therapeutics AG |
$40.94 | $4.91 B | -21.43 | 407 | $371.21 M |
DNA
Ginkgo Bioworks Holdings, Inc. |
$9.37 | $1.14 B | -1.2 | 1218 | $251.46 M |
EDIT
Editas Medicine, Inc. |
$1.21 | $435.86 M | -2.56 | 265 | $78.12 M |
ICPT
Intercept Pharmaceuticals, Inc. |
$19.00 | $794.69 M | -17.43 | 341 | $285.71 M |
KRYS
Krystal Biotech, Inc. |
$158.52 | $4.70 B | 75.42 | 229 | $50.70 M |
MDGL
Madrigal Pharmaceuticals, Inc. |
$312.00 | $5.21 B | -10.55 | 376 | $0 |
MRNA
Moderna, Inc. |
$40.27 | $57.87 B | -9.69 | 5600 | $6.85 B |
NTLA
Intellia Therapeutics, Inc. |
$12.05 | $2.19 B | -4.23 | 526 | $36.28 M |
PTCT
PTC Therapeutics, Inc. |
$45.35 | $2.80 B | -4.75 | 988 | $937.82 M |
REGN
Regeneron Pharmaceuticals, Inc. |
$714.47 | $108.69 B | 29.65 | 14165 | $13.12 B |
RETA
Reata Pharmaceuticals, Inc. |
$172.36 | $6.57 B | -66.29 | 321 | $2.22 M |
SGEN
Seagen Inc. |
$228.74 | $43.15 B | -57.19 | 3256 | $1.96 B |
SRPT
Sarepta Therapeutics, Inc. |
$121.90 | $11.66 B | 286.79 | 1314 | $1.24 B |
VERV
Verve Therapeutics, Inc. |
$5.77 | $409.24 M | -1.82 | 255 | $11.76 M |
VKTX
Viking Therapeutics, Inc. |
$42.35 | $6.17 B | -60.86 | 30 | $0 |